1. Home
  2. SCLXW vs NHPAP Comparison

SCLXW vs NHPAP Comparison

Compare SCLXW & NHPAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

HOLD

Current Price

$0.16

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Logo National Healthcare Properties Inc. 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock

NHPAP

National Healthcare Properties Inc. 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock

HOLD

Current Price

$19.39

Market Cap

0.0

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLXW
NHPAP
Founded
N/A
N/A
Country
United States
United States
Employees
31
26
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLXW
NHPAP
Price
$0.16
$19.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0K
N/A
Earning Date
03-07-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,152,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.02
N/A
52 Week Low
$0.18
N/A
52 Week High
$0.18
N/A

Technical Indicators

Market Signals
Indicator
SCLXW
NHPAP
Relative Strength Index (RSI) 41.02 74.43
Support Level $0.17 $19.26
Resistance Level $0.21 $19.50
Average True Range (ATR) 0.03 0.26
MACD -0.00 0.03
Stochastic Oscillator 30.64 86.13

Price Performance

Historical Comparison
SCLXW
NHPAP

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About NHPAP National Healthcare Properties Inc. 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock

National Healthcare Properties Inc is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing operating properties (SHOP) and outpatient medical facilities (OMF), located in the United States. The company has SHOPs and OMFs as two reportable business segments for management and internal financial reporting purposes. OMF consists of physicians' offices and examination rooms, hospitals, pharmacies, other facilities. SHOP consist of assisted living facilities, memory care facilities, Independent Living facilities. Majority of revenue is from OMFs segment.

Share on Social Networks: